113 related articles for article (PubMed ID: 709519)
1. Measurement of carcinoembryonic antigen in patients with bronchogenic carcinoma.
Dent PB; McCulloch PB; Wesley-James O; MacLaren R; Muirhead W; Dunnett CW
Cancer; 1978 Sep; 42(3 Suppl):1484-91. PubMed ID: 709519
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the early postoperative serum carcinoembryonic antigen time-course as a prognostic tool for bronchogenic carcinoma.
Yoshimasu T; Miyoshi S; Maebeya S; Suzuma T; Bessho T; Hirai I; Tanino H; Arimoto J; Naito Y
Cancer; 1997 Apr; 79(8):1533-40. PubMed ID: 9118035
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma.
Concannon JP; Dalbow MH; Hodgson SE; Headings JJ; Markopoulos E; Mitchell J; Cushing WJ; Liebler GA
Cancer; 1978 Sep; 42(3 Suppl):1477-83. PubMed ID: 709518
[No Abstract] [Full Text] [Related]
4. Correlation of elevated C1q binding activity and carcinoembryonic antigen levels with clinical features and prognosis in bronchogenic carcinoma.
Dent PB; Louis JA; McCulloch PB; Dunnett CW; Cerottini JC
Cancer; 1980 Jan; 45(1):130-6. PubMed ID: 6243237
[TBL] [Abstract][Full Text] [Related]
5. [Serum beta 2-microglobulin and carcinoembryonic antigen in patients with bronchogenic carcinoma].
Cha RJ; Chen SJ; Xiao CZ; Liang XL; Zhou NK
Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):342-4. PubMed ID: 3552534
[TBL] [Abstract][Full Text] [Related]
6. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
7. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
[TBL] [Abstract][Full Text] [Related]
8. Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9.
Buccheri GF; Ferrigno D; Sartoris AM; Violante B; Vola F; Curcio A
Cancer; 1987 Jul; 60(1):42-50. PubMed ID: 3472637
[TBL] [Abstract][Full Text] [Related]
9. [Blood chemical parameters in the monitoring of inoperable bronchogenic carcinoma].
Barberis S; Ciotta D; Fusaro E; Galietti F; Giorgis GE; Oliaro A; Scappaticci E
Minerva Med; 1986 Oct; 77(39):1789-92. PubMed ID: 3774198
[TBL] [Abstract][Full Text] [Related]
10. Tumor markers kinetic in malignant lung neoplasms.
Cristofori R; Aimo G; Mengozzi G; Oliaro A; Revello F; Rapellino M
J Cardiovasc Surg (Torino); 1999 Apr; 40(2):299-305. PubMed ID: 10350122
[TBL] [Abstract][Full Text] [Related]
11. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
12. [Tumor markers as prognostic factors in non-small-cell bronchial carcinoma].
Nieder C; Nestle U; Ukena D; Niewald M; Sybrecht GW; Schnabel K
Strahlenther Onkol; 1995 Oct; 171(10):587-93. PubMed ID: 8571178
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic antigen (CEA) in patients with malignant and non-malignant diseases.
Alsabti EA; Kamel A
Neoplasma; 1979; 26(5):603-9. PubMed ID: 230422
[TBL] [Abstract][Full Text] [Related]
15. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical staining for CEA in small cell carcinoma of lung predicts clinical usefulness of the plasma assay.
Goslin RH; O'Brien MJ; Skarin AT; Zamcheck N
Cancer; 1983 Jul; 52(2):301-6. PubMed ID: 6305471
[TBL] [Abstract][Full Text] [Related]
17. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W
BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer.
Sculier JP; Feld R; Evans WK; Shepherd FA; DeBoer G; Malkin DG; Malkin A
J Clin Oncol; 1985 Oct; 3(10):1349-54. PubMed ID: 2995598
[TBL] [Abstract][Full Text] [Related]
19. Tissue polypeptide antigen in bronchogenic carcinoma.
Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
[TBL] [Abstract][Full Text] [Related]
20. Tissue polypeptide antigen and carcinoembryonic antigen as tumor markers in lung cancer.
Lee YC; Yang PC; Kuo SH; Luh KT
J Formos Med Assoc; 1991 Jul; 90(7):631-6. PubMed ID: 1681012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
